After suspension of execs, PS-DBM vows to press on with procurement, admin reforms | Inquirer News

After suspension of execs, PS-DBM vows to press on with procurement, admin reforms

By: - Reporter / @BPinlacINQ
/ 03:47 PM March 23, 2023

The P3 billion high-yield investment of the  PS-DBM in government banks that was flagged by the COA is intact, according to its chief.

PS-DBM logo

MANILA, Philippines — Despite the cloud of controversy surrounding the government’s pandemic supply purchases and the suspension of several officials, the Procurement Service of the Department of Budget and Management (PS-DBM) remains committed to its procurement and administrative reforms.

In a Thursday statement, the PS-DBM accepts the verdict of the Ombudsman, mandating a preventive suspension for incumbent and former officials involved in the controversial multibillion-peso deals awarded by the Duterte administration to Pharmally Pharmaceutical Corp at the peak of the COVID-19 crisis.

Article continues after this advertisement

READ: Ombudsman suspends 33 execs in Pharmally mess

The agency assured the public that it would implement the order from the Ombudsman within the given time frame.

FEATURED STORIES

“Under the current leadership, the PS-DBM shall continue to implement and institute crucial procurement and administrative reforms while implementing zero tolerance on irregularities and any form of corruption,” it said.

Aside from officials of the PS-DBM, Health Assistant Secretary Nestor Santiago Jr. and former Budget Undersecretary Lloyd Christopher Lao, who led the PS-DBM when it entered into the multi-billion deal with Pharmally, were also slapped with a six-month suspension without pay.

Article continues after this advertisement

Senator Risa Hontiveros and former Senator Richard Gordon, erstwhile chair of the chamber’s blue ribbon panel, filed a complaint that led to the Ombudsman’s ruling

Article continues after this advertisement

Two years ago, Gordon led a Senate inquiry into the suspicious supply contracts between the government and Pharmally, a startup company with a meager paid-up capital of P625,000.

The blue ribbon committee report said then-President Rodrigo Duterte should be among those held liable for the anomalous deal since he appointed Michael Yang, a Chinese national suspected of being the real owner of Pharmally, as an economic adviser in 2018.

RELATED STORIES:

Pharmally scandal: When middlemen profit even during a pandemic

Pharmally report vs Duterte awaits senators’ nod

2021: Pharmally scandal rubs salt on pandemic wounds

JMS/abc
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Office of the Ombudsman, Pharmally, PS-DBM

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.